+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Plasma Therapy Market by Technology (Hybrid Releasate, Platelet-Poor Plasma, Platelet-Rich Fibrin), Therapeutic Area (Autoimmune Disorders, Cardiovascular Repair, Dermatology & Aesthetics), End User, Source, Application, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5889293
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Plasma Therapy Market grew from USD 389.19 million in 2024 to USD 437.66 million in 2025. It is expected to continue growing at a CAGR of 12.35%, reaching USD 782.92 million by 2030.

Unveiling the Strategic Significance of Plasma Therapy in Modern Healthcare and Its Transformative Potential for Patient Outcomes

Plasma therapy represents one of the most promising frontiers in regenerative medicine, harnessing the healing potential of blood-derived components to accelerate tissue repair and modulate immune responses. Its applications span a diverse array of clinical disciplines, from orthopedic interventions to dermatological rejuvenation, underscoring its versatility and broad therapeutic appeal. As precision medicine continues to gain traction, plasma therapy stands out as a customizable treatment modality capable of addressing individual patient pathology with targeted biological interventions.

Moreover, scientific advances in separation technologies and formulation processes have amplified the efficacy and consistency of plasma-based products. The refinement of centrifugation protocols and the emergence of novel additives have enhanced the concentration and stability of platelets, growth factors, and cytokines, leading to improved clinical outcomes. Concurrent regulatory developments have further legitimized plasma therapy, with updated guidelines paving the way for streamlined approvals and increased adoption among healthcare providers.

This executive summary distills critical insights from a comprehensive analysis of the plasma therapy market, synthesizing recent innovations, policy impacts, and competitive dynamics. By articulating key trends and strategic imperatives, it equips stakeholders with the knowledge required to navigate a rapidly evolving landscape. Readers will gain a cohesive understanding of transformative shifts, noteworthy companies, regional variations, and actionable recommendations that collectively shape the future trajectory of plasma therapy.

In addition to its clinical promise, plasma therapy is attracting significant interest from investors and cross-disciplinary research initiatives. Collaborative partnerships between academic institutions, biotechnology startups, and established medical device companies are fostering a vibrant ecosystem of innovation. These synergies are unlocking new pathways for product development and commercialization, while rigorous clinical trials continue to validate safety and efficacy across emerging indications. With these converging forces, plasma therapy is poised to redefine therapeutic paradigms and deliver enhanced patient outcomes on a global scale.

Exploring Recent Breakthroughs and Emerging Trends That Are Redefining the Plasma Therapy Landscape Across Therapeutic Domains

Recent years have witnessed a dynamic metamorphosis in the plasma therapy landscape, driven by breakthroughs in bioengineering and evolving clinical protocols. Next-generation separation platforms employing microfluidic and acoustic technologies have redefined product purity, enabling practitioners to isolate specific cellular and protein fractions with unprecedented precision. This heightened specificity has, in turn, expanded the scope of therapeutic applications, facilitating personalized regimens tailored to individual patient biomarkers.

Furthermore, regulatory frameworks are adapting to support innovation, with accelerated pathways for regenerative therapies and updated classifications that accommodate emerging product formats. These policy shifts have reduced barriers to market entry, accelerating the translation of laboratory discoveries into commercial offerings. At the same time, digital health enablers, including artificial intelligence-augmented diagnostics and telemedicine platforms, are enhancing patient engagement, driving treatment adherence, and optimizing outcome monitoring.

The proliferation of point-of-care systems represents another critical vector of transformation. Portable devices capable of on-site plasma processing are democratizing access to therapy, particularly in ambulatory surgical centers and remote care facilities. Simultaneously, strategic alliances among biotechnology firms, device manufacturers, and healthcare providers are forging integrated value chains that streamline supply logistics and support scale-up initiatives. As these cross-sector collaborations gain momentum, the plasma therapy ecosystem is evolving toward a more agile and responsive model, characterized by seamless integration of scientific innovation, regulatory support, and commercial execution.

Transitioning from traditional centralized production models, the industry is increasingly embracing distributed manufacturing networks supplemented by digital quality control systems. This shift not only mitigates supply bottlenecks but also aligns with broader trends toward on-demand personalized medicine. As stakeholders continue to refine these new approaches, the stage is set for a sustained wave of innovation that will recalibrate competitive dynamics and unlock novel therapeutic avenues.

Assessing How the Introduction of New United States Tariffs in 2025 Is Shaping Supply Chains Pricing Structures and Global Trade Dynamics

Introduction of new United States tariffs in 2025 has introduced a pivotal variable that is reshaping supply chains and pricing architectures for plasma therapy stakeholders. By imposing additional levies on imported equipment and raw material components, this policy action has exerted upward pressure on production costs, compelling manufacturers to reevaluate sourcing strategies and operational footprints. As a consequence, cost absorption at various junctures of the value chain has emerged as a critical challenge for both device producers and clinical service providers.

Moreover, the tariff-induced cost differentials are influencing procurement decisions among healthcare institutions. Hospitals and specialty clinics are increasingly exploring domestic manufacturing partnerships to mitigate exposure to cross-border duties, thereby accelerating the localization of supply networks. Concurrently, suppliers are negotiating revised contractual terms, leveraging volume commitments and long-term agreements to amortize tariff impacts. These tactical responses underscore the adaptability of industry actors in navigating evolving trade landscapes.

In addition, the tariffs have amplified investment in logistics optimization and alternative sourcing. Stakeholders are deploying advanced forecasting tools and digital supply chain management platforms to identify cost-efficient routes and buffer stocks. They are also cultivating relationships with domestic component manufacturers, integrating backward to safeguard against future trade disruptions. While these measures have introduced complexity into operational models, they have simultaneously fostered greater supply resilience.

Ultimately, the cumulative impact of the 2025 tariffs is catalyzing a strategic reorientation within the plasma therapy market. Companies that proactively adjust their procurement frameworks, invest in local capacity building, and harness data-driven supply chain intelligence will be best positioned to sustain margins and deliver uninterrupted patient care.

Looking ahead, these tariff dynamics underscore the importance of regulatory foresight and scenario planning. Enterprises that incorporate comprehensive trade impact assessments into their strategic roadmaps can better anticipate cost fluctuations and deploy preemptive mitigation tactics. Through this lens, the current tariff environment, while challenging, also presents an opportunity for market leaders to fortify supply chain sovereignty and cultivate competitive differentiation.

Illuminating Critical Market Segmentation Insights Spanning Technology Therapeutic Area End Users Sources Applications and Distribution Channels

Analyses based on the underlying technology reveal distinct performance and adoption trajectories for various plasma formulations. Hybrid Releasate products combine soluble factors with structural matrices to support controlled release, while platelet-poor plasma formulations offer targeted anti-inflammatory effects through reduced cell counts. Conversely, platelet-rich fibrin devices excel in sustained growth factor delivery, and platelet-rich plasma therapies remain the most widely investigated modality due to their high concentration of platelets and cytokines.

In exploring therapeutic area segmentation, autoimmune disorder applications underscore the immunomodulatory potential of plasma derivatives, whereas cardiovascular repair initiatives leverage angiogenic factors to stimulate neovascularization. The dermatology and aesthetic segment encompasses hair restoration protocols, advanced techniques in scar revision, and skin rejuvenation treatments that harness plasma’s regenerative properties. Orthopedic interventions include approaches for fracture healing, precision-guided joint injections, and tendon repair strategies optimized for mechanical reinforcement. Wound healing applications focus on diabetic ulcer management, pressure ulcer resolution, and venous ulcer therapies, each benefiting from localized growth factor release.

End user segmentation highlights the growing role of ambulatory surgical centers in delivering same-day plasma interventions, while expanding home care settings facilitate at-home administration supported by simplified delivery devices. Hospitals continue to serve as primary hubs for complex procedures, and specialty clinics are emerging as centers of excellence for niche indications. Source segmentation differentiates between allogeneic products sourced from donor plasma and autologous therapies derived from the patient’s own blood, with the latter gaining traction for its immunocompatibility advantages.

Application insights span cosmetic procedures where plasma therapies augment aesthetic outcomes, dental procedures that rely on accelerated osseointegration, musculoskeletal injury treatments focused on soft tissue regeneration, and ophthalmology procedures that incorporate plasma-derived matrices for corneal repair. Distribution channel analysis reveals that hospital pharmacies remain central to product dissemination, while online channels-whether manufacturer direct platforms or third-party marketplaces-are democratizing access. Retail pharmacies also play a complementary role, particularly in providing prefilled kits and ancillary supplies for outpatient settings.

Dissecting Regional Variations and Growth Drivers in the Plasma Therapy Sector Across the Americas Europe Middle East & Africa and Asia-Pacific Markets

In the Americas region, established healthcare infrastructures and robust reimbursement frameworks drive widespread clinical adoption of plasma therapy. North American markets benefit from strong academic research collaborations and advanced manufacturing ecosystems that support rapid scale-up of both autologous and allogeneic products. Meanwhile, Latin American countries are gradually integrating plasma interventions into outpatient clinics, fueled by cost-effective point-of-care devices and growing clinician awareness. The interplay between public health initiatives and private payers continues to shape market dynamics, as stakeholders navigate regulatory pathways and pricing negotiations.

Across Europe, Middle East & Africa, heterogeneity in regulatory standards and market maturity presents both challenges and opportunities. Western European nations lead in clinical trials and early adoption, leveraging harmonized medical device directives that facilitate cross-border commercialization. In contrast, rapidly developing markets within the Middle East and Africa are characterized by emergent infrastructure investments and increasing demand for aesthetic and regenerative applications. Strategic partnerships between regional distributors and global manufacturers are instrumental in expanding reach, supported by localized training programs that cultivate professional expertise.

The Asia-Pacific landscape is defined by accelerating innovation and diverse market drivers. Japan and Australia exhibit high adoption rates, underpinned by favorable regulatory reforms and strong institutional capacities. Southeast Asian economies are experiencing a surge in medical tourism for dermatology and orthopedic procedures, positioning plasma therapy as a competitive offering. China and India are scaling domestic production capabilities and fostering local research consortia, which are instrumental in reducing import dependence. Across the region, digital health integration and cost-sensitive procurement models continue to influence distribution strategies and patient access, enabling broader dissemination of plasma-based therapies.

Profiling Leading Companies and Strategic Partnerships Driving Innovation Commercialization and Competitive Dynamics in Plasma Therapy

The competitive landscape of the plasma therapy market is characterized by a blend of established medical device manufacturers, agile biotechnology firms, and innovative start-ups, each vying for leadership in distinct subsegments. Several prominent players have distinguished themselves through robust pipelines of next-generation plasma formulations, leveraging proprietary separation platforms and advanced growth factor stabilization techniques. These companies are strategically positioning themselves to capture both high-value therapeutic applications and expanding aesthetic use cases.

Research and development investments are a key differentiator among market participants. Leading firms are channeling resources into clinical trials that explore novel indications, such as neuroregeneration and chronic wound management. Concurrently, several emerging players are pioneering modular point-of-care systems designed for decentralized settings, which promise to lower operational barriers for clinic-based administration. This dual focus on product innovation and delivery infrastructure underscores the industry’s commitment to holistic solutions.

Strategic collaborations and targeted acquisitions have also reshaped competitive dynamics. Cross-industry alliances between device manufacturers and biopharmaceutical companies have accelerated co-development of hybrid therapies, while acquisitions of boutique plasma processing specialists have enabled established corporations to expand their technology portfolios. These transactions reflect a broader trend toward consolidation, as market leaders seek to integrate complementary capabilities and reinforce their value propositions.

Looking ahead, successful companies will be those that balance deep scientific expertise with agile commercialization strategies. Firms that can adeptly navigate regulatory complexities, demonstrate clinical differentiation, and forge enduring partnerships across the value chain are poised to command premium positioning. Moreover, companies that invest in scalable manufacturing and digital quality assurance frameworks will be well equipped to meet evolving demand patterns and sustain long-term growth trajectories.

Formulating Actionable Recommendations to Empower Industry Leaders to Navigate Challenges Scale Innovations and Capture Opportunities in Plasma Therapy

To navigate the evolving plasma therapy landscape, industry leaders must adopt a proactive approach to supply chain resilience. Establishing multi-sourcing frameworks and fostering collaborative relationships with domestic raw material suppliers can mitigate the impacts of trade policy fluctuations. In parallel, integrating predictive analytics into procurement processes will enable real-time visibility into inventory levels and demand signals, thereby reducing risk and optimizing cost structures.

Another pivotal recommendation is to prioritize the development of personalized treatment protocols. By investing in biomarker research and stratified patient profiling, companies can enhance therapeutic efficacy and differentiate their offerings. Furthermore, establishing centers of excellence for clinical research and training not only builds clinician confidence but also accelerates adoption through evidence-based validation. These centers can serve as hubs for best-practice dissemination and facilitate peer-to-peer knowledge exchange.

Embracing digital health solutions will be instrumental in enhancing patient engagement and outcome tracking. Deploying telemedicine platforms, mobile health applications, and connected monitoring devices can extend the reach of plasma therapy beyond traditional care settings. Such tools support remote consultations, adherence monitoring, and data-driven personalization, thereby improving patient satisfaction and expanding market penetration.

Finally, strategic collaborations with payers and regulatory bodies are essential to securing reimbursement and accelerating market access. Engaging early with health technology assessment agencies and advocating for value-based reimbursement models can reduce barriers to entry. Additionally, pursuing joint ventures with specialty clinic networks and academic institutions will strengthen distribution channels and reinforce thought leadership. By executing these recommendations, industry leaders can capitalize on emerging opportunities, fortify competitive positioning, and drive sustainable growth in the plasma therapy market.

Detailing the Comprehensive Research Methodology Underpinning Data Collection Analysis and Validation Processes in Plasma Therapy Market Evaluation

This research undertook a comprehensive methodology to ensure the integrity and reliability of insights into the plasma therapy market. The process commenced with an exhaustive review of secondary sources, including peer-reviewed journals, regulatory publications, and clinical trial repositories. These materials provided a foundational understanding of evolving technologies, therapeutic applications, and key regulatory frameworks.

Following the secondary research phase, primary data was collected through structured interviews with a cross-section of industry stakeholders. Participants included academic researchers, clinical practitioners, C-level executives from device manufacturers, and distribution channel experts. These interviews elucidated firsthand perspectives on market drivers, technology adoption hurdles, and strategic roadmaps. All interviews adhered to confidentiality protocols and were systematically documented to support analytical rigor.

Quantitative data was then validated through triangulation techniques, comparing reported figures against multiple independent sources. This cross-validation process enhanced the accuracy of segmentation mappings and regional analysis. Proprietary models were applied to interpret tariff impacts, distribution dynamics, and competitive positioning, drawing upon scenario planning frameworks to capture potential market evolutions.

Finally, analytical findings underwent iterative reviews by subject matter experts to ensure factual correctness and contextual relevance. Feedback loops with clinical advisors and supply chain specialists refined the narrative and bolstered the report’s applicability. This methodological approach, integrating both qualitative and quantitative techniques, underpins the credibility of the insights and equips decision-makers with a robust foundation for strategic planning.

Synthesizing Key Findings and Strategic Implications to Provide a Cohesive Perspective on the Current State and Future of Plasma Therapy

In synthesizing the myriad insights from this analysis, it becomes clear that plasma therapy is at a pivotal juncture characterized by rapid technological innovation, evolving regulatory landscapes, and shifting trade dynamics. The convergence of advanced separation platforms, personalized treatment protocols, and digital health integrations is redefining therapeutic possibilities, while policy developments such as the 2025 United States tariffs are catalyzing strategic supply chain adaptations.

Regional variations and segmentation nuances further underscore the complexity of the market. Stakeholders must navigate diverse regulatory standards in Europe Middle East & Africa, leverage robust research ecosystems in North America, and address cost-sensitive demand models in the Asia-Pacific region. Meanwhile, companies that excel in R&D investment, forge strategic partnerships, and optimize distribution channels are securing competitive advantages and shaping the path forward.

Ultimately, the future of plasma therapy hinges on industry leaders’ ability to embrace an integrated approach that synthesizes innovation with operational resilience. By aligning strategic investments with actionable recommendations, organizations can unlock new avenues for growth and deliver enhanced patient outcomes. This report aims to provide stakeholders with a cohesive understanding of the market landscape and a strategic compass to navigate forthcoming challenges and opportunities.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technology
    • Hybrid Releasate
    • Platelet-Poor Plasma
    • Platelet-Rich Fibrin
    • Platelet-Rich Plasma
  • Therapeutic Area
    • Autoimmune Disorders
    • Cardiovascular Repair
    • Dermatology & Aesthetics
      • Hair Restoration
      • Scar Revision
      • Skin Rejuvenation
    • Orthopedics
      • Fracture Healing
      • Joint Injections
      • Tendon Repair
    • Wound Healing
      • Diabetic Ulcers
      • Pressure Ulcers
      • Venous Ulcers
  • End User
    • Ambulatory Surgical Centers
    • Home Care Settings
    • Hospitals
    • Specialty Clinics
  • Source
    • Allogeneic
    • Autologous
  • Application
    • Cosmetic Procedures
    • Dental Procedures
    • Musculoskeletal Injuries
    • Ophthalmology Procedures
  • Distribution Channel
    • Hospital Pharmacies
    • Online Channels
      • Manufacturer Direct
      • Marketplace Platforms
    • Retail Pharmacies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • CSL Behring GmbH
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Biotest AG
  • Kedrion S.p.A.
  • LFB S.A.
  • Bio Products Laboratory Ltd
  • ADMA Biologics, Inc.
  • Stichting Sanquin Bloedvoorziening

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of hyperimmune plasma products targeting emerging viral variants in COVID-19 treatment strategies
5.2. Adoption of automated plasmapheresis systems to enhance donor throughput and reduce processing times
5.3. Integration of artificial intelligence algorithms for predictive donor screening to improve plasma quality
5.4. Development of pathogen reduction technologies to ensure safety in convalescent plasma therapies
5.5. Rising collaborations between biotech firms and blood banks for large-scale immunoglobulin production
5.6. Regulatory evolution in global markets enabling emergency use authorization for novel plasma therapeutics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Plasma Therapy Market, by Technology
8.1. Introduction
8.2. Hybrid Releasate
8.3. Platelet-Poor Plasma
8.4. Platelet-Rich Fibrin
8.5. Platelet-Rich Plasma
9. Plasma Therapy Market, by Therapeutic Area
9.1. Introduction
9.2. Autoimmune Disorders
9.3. Cardiovascular Repair
9.4. Dermatology & Aesthetics
9.4.1. Hair Restoration
9.4.2. Scar Revision
9.4.3. Skin Rejuvenation
9.5. Orthopedics
9.5.1. Fracture Healing
9.5.2. Joint Injections
9.5.3. Tendon Repair
9.6. Wound Healing
9.6.1. Diabetic Ulcers
9.6.2. Pressure Ulcers
9.6.3. Venous Ulcers
10. Plasma Therapy Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Home Care Settings
10.4. Hospitals
10.5. Specialty Clinics
11. Plasma Therapy Market, by Source
11.1. Introduction
11.2. Allogeneic
11.3. Autologous
12. Plasma Therapy Market, by Application
12.1. Introduction
12.2. Cosmetic Procedures
12.3. Dental Procedures
12.4. Musculoskeletal Injuries
12.5. Ophthalmology Procedures
13. Plasma Therapy Market, by Distribution Channel
13.1. Introduction
13.2. Hospital Pharmacies
13.3. Online Channels
13.3.1. Manufacturer Direct
13.3.2. Marketplace Platforms
13.4. Retail Pharmacies
14. Americas Plasma Therapy Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Plasma Therapy Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Plasma Therapy Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. CSL Behring GmbH
17.3.2. Grifols, S.A.
17.3.3. Takeda Pharmaceutical Company Limited
17.3.4. Octapharma AG
17.3.5. Biotest AG
17.3.6. Kedrion S.p.A.
17.3.7. LFB S.A.
17.3.8. Bio Products Laboratory Ltd
17.3.9. ADMA Biologics, Inc.
17.3.10. Stichting Sanquin Bloedvoorziening
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. PLASMA THERAPY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PLASMA THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PLASMA THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PLASMA THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PLASMA THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PLASMA THERAPY MARKET SIZE, BY SOURCE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PLASMA THERAPY MARKET SIZE, BY SOURCE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PLASMA THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PLASMA THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. PLASMA THERAPY MARKET: RESEARCHAI
FIGURE 28. PLASMA THERAPY MARKET: RESEARCHSTATISTICS
FIGURE 29. PLASMA THERAPY MARKET: RESEARCHCONTACTS
FIGURE 30. PLASMA THERAPY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PLASMA THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PLASMA THERAPY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PLASMA THERAPY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PLASMA THERAPY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PLASMA THERAPY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PLASMA THERAPY MARKET SIZE, BY HYBRID RELEASATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PLASMA THERAPY MARKET SIZE, BY HYBRID RELEASATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PLASMA THERAPY MARKET SIZE, BY PLATELET-POOR PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PLASMA THERAPY MARKET SIZE, BY PLATELET-POOR PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PLASMA THERAPY MARKET SIZE, BY PLATELET-RICH FIBRIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PLASMA THERAPY MARKET SIZE, BY PLATELET-RICH FIBRIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PLASMA THERAPY MARKET SIZE, BY PLATELET-RICH PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PLASMA THERAPY MARKET SIZE, BY PLATELET-RICH PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PLASMA THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PLASMA THERAPY MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PLASMA THERAPY MARKET SIZE, BY CARDIOVASCULAR REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PLASMA THERAPY MARKET SIZE, BY CARDIOVASCULAR REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PLASMA THERAPY MARKET SIZE, BY HAIR RESTORATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PLASMA THERAPY MARKET SIZE, BY HAIR RESTORATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PLASMA THERAPY MARKET SIZE, BY SCAR REVISION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PLASMA THERAPY MARKET SIZE, BY SCAR REVISION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PLASMA THERAPY MARKET SIZE, BY SKIN REJUVENATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PLASMA THERAPY MARKET SIZE, BY SKIN REJUVENATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PLASMA THERAPY MARKET SIZE, BY FRACTURE HEALING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PLASMA THERAPY MARKET SIZE, BY FRACTURE HEALING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PLASMA THERAPY MARKET SIZE, BY JOINT INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PLASMA THERAPY MARKET SIZE, BY JOINT INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PLASMA THERAPY MARKET SIZE, BY TENDON REPAIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PLASMA THERAPY MARKET SIZE, BY TENDON REPAIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PLASMA THERAPY MARKET SIZE, BY DIABETIC ULCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PLASMA THERAPY MARKET SIZE, BY DIABETIC ULCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PLASMA THERAPY MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PLASMA THERAPY MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PLASMA THERAPY MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PLASMA THERAPY MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PLASMA THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PLASMA THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PLASMA THERAPY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PLASMA THERAPY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PLASMA THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PLASMA THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PLASMA THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PLASMA THERAPY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PLASMA THERAPY MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PLASMA THERAPY MARKET SIZE, BY ALLOGENEIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PLASMA THERAPY MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PLASMA THERAPY MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PLASMA THERAPY MARKET SIZE, BY COSMETIC PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PLASMA THERAPY MARKET SIZE, BY COSMETIC PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PLASMA THERAPY MARKET SIZE, BY DENTAL PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PLASMA THERAPY MARKET SIZE, BY DENTAL PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PLASMA THERAPY MARKET SIZE, BY MUSCULOSKELETAL INJURIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PLASMA THERAPY MARKET SIZE, BY MUSCULOSKELETAL INJURIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PLASMA THERAPY MARKET SIZE, BY OPHTHALMOLOGY PROCEDURES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PLASMA THERAPY MARKET SIZE, BY OPHTHALMOLOGY PROCEDURES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PLASMA THERAPY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PLASMA THERAPY MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PLASMA THERAPY MARKET SIZE, BY MANUFACTURER DIRECT, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PLASMA THERAPY MARKET SIZE, BY MANUFACTURER DIRECT, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PLASMA THERAPY MARKET SIZE, BY MARKETPLACE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PLASMA THERAPY MARKET SIZE, BY MARKETPLACE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PLASMA THERAPY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PLASMA THERAPY MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 125. UNITED STATES PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 126. UNITED STATES PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES PLASMA THERAPY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 139. CANADA PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 140. CANADA PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 141. CANADA PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 142. CANADA PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 143. CANADA PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 144. CANADA PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 145. CANADA PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 146. CANADA PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 147. CANADA PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 148. CANADA PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 149. CANADA PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. CANADA PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. CANADA PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 152. CANADA PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 153. CANADA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 155. CANADA PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 156. CANADA PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 157. CANADA PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 158. CANADA PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. MEXICO PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. MEXICO PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 162. MEXICO PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 163. MEXICO PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 164. MEXICO PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 165. MEXICO PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 166. MEXICO PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 167. MEXICO PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 168. MEXICO PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 169. MEXICO PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. MEXICO PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. MEXICO PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 172. MEXICO PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 173. MEXICO PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 174. MEXICO PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 175. MEXICO PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 176. MEXICO PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 177. MEXICO PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 178. MEXICO PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 185. BRAZIL PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 186. BRAZIL PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 187. BRAZIL PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 188. BRAZIL PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 189. BRAZIL PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 190. BRAZIL PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 191. BRAZIL PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 192. BRAZIL PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 193. BRAZIL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. BRAZIL PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. BRAZIL PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. BRAZIL PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 205. ARGENTINA PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 206. ARGENTINA PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 207. ARGENTINA PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 208. ARGENTINA PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 209. ARGENTINA PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. ARGENTINA PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. ARGENTINA PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 212. ARGENTINA PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 213. ARGENTINA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. ARGENTINA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. ARGENTINA PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 216. ARGENTINA PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 217. ARGENTINA PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 218. ARGENTINA PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 227. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 228. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 229. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 232. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 233. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 236. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 237. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 238. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 239. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 240. EUROPE, MIDDLE EAST & AFRICA PLASMA THERAPY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 247. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 248. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 249. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 250. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 251. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 254. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 255. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 258. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 259. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 260. UNITED KINGDOM PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. GERMANY PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. GERMANY PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 264. GERMANY PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 265. GERMANY PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 266. GERMANY PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 267. GERMANY PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 268. GERMANY PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 269. GERMANY PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 270. GERMANY PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 271. GERMANY PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. GERMANY PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. GERMANY PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 274. GERMANY PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 275. GERMANY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 276. GERMANY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 277. GERMANY PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. GERMANY PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. GERMANY PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 280. GERMANY PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. FRANCE PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. FRANCE PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 284. FRANCE PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 285. FRANCE PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 286. FRANCE PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 287. FRANCE PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 288. FRANCE PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 289. FRANCE PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 290. FRANCE PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 291. FRANCE PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. FRANCE PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. FRANCE PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 294. FRANCE PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 295. FRANCE PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. FRANCE PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. FRANCE PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 298. FRANCE PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 299. FRANCE PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 300. FRANCE PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 307. RUSSIA PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 308. RUSSIA PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 309. RUSSIA PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 310. RUSSIA PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 311. RUSSIA PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. RUSSIA PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. RUSSIA PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 314. RUSSIA PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 315. RUSSIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 316. RUSSIA PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 317. RUSSIA PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 318. RUSSIA PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 319. RUSSIA PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 320. RUSSIA PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 321. ITALY PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 322. ITALY PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 323. ITALY PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 324. ITALY PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 325. ITALY PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 326. ITALY PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 327. ITALY PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 328. ITALY PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 329. ITALY PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 330. ITALY PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 331. ITALY PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. ITALY PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. ITALY PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-2024 (USD MILLION)
TABLE 334. ITALY PLASMA THERAPY MARKET SIZE, BY SOURCE, 2025-2030 (USD MILLION)
TABLE 335. ITALY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 336. ITALY PLASMA THERAPY MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 337. ITALY PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. ITALY PLASMA THERAPY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. ITALY PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2018-2024 (USD MILLION)
TABLE 340. ITALY PLASMA THERAPY MARKET SIZE, BY ONLINE CHANNELS, 2025-2030 (USD MILLION)
TABLE 341. SPAIN PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 342. SPAIN PLASMA THERAPY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 343. SPAIN PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 344. SPAIN PLASMA THERAPY MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 345. SPAIN PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2018-2024 (USD MILLION)
TABLE 346. SPAIN PLASMA THERAPY MARKET SIZE, BY DERMATOLOGY & AESTHETICS, 2025-2030 (USD MILLION)
TABLE 347. SPAIN PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2018-2024 (USD MILLION)
TABLE 348. SPAIN PLASMA THERAPY MARKET SIZE, BY ORTHOPEDICS, 2025-2030 (USD MILLION)
TABLE 349. SPAIN PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2018-2024 (USD MILLION)
TABLE 350. SPAIN PLASMA THERAPY MARKET SIZE, BY WOUND HEALING, 2025-2030 (USD MILLION)
TABLE 351. SPAIN PLASMA THERAPY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. SPAIN PLASMA THERAPY MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. SPAIN PLASMA THERAPY MARKET SIZE, BY SOURCE, 2018-

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Plasma Therapy market report include:
  • CSL Behring GmbH
  • Grifols, S.A.
  • Takeda Pharmaceutical Company Limited
  • Octapharma AG
  • Biotest AG
  • Kedrion S.p.A.
  • LFB S.A.
  • Bio Products Laboratory Ltd
  • ADMA Biologics, Inc.
  • Stichting Sanquin Bloedvoorziening

Table Information